1447 related articles for article (PubMed ID: 14502282)
1. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.
Uyttenhove C; Pilotte L; Théate I; Stroobant V; Colau D; Parmentier N; Boon T; Van den Eynde BJ
Nat Med; 2003 Oct; 9(10):1269-74. PubMed ID: 14502282
[TBL] [Abstract][Full Text] [Related]
2. [A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase].
Van den Eynde B
Bull Mem Acad R Med Belg; 2003; 158(7-9):356-63; discussion 364-5. PubMed ID: 15132006
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan pyrrole ring cleavage enzymes in placenta.
Minatogawa Y; Suzuki S; Ando Y; Tone S; Takikawa O
Adv Exp Med Biol; 2003; 527():425-34. PubMed ID: 15206760
[TBL] [Abstract][Full Text] [Related]
4. Prevention of allogeneic fetal rejection by tryptophan catabolism.
Munn DH; Zhou M; Attwood JT; Bondarev I; Conway SJ; Marshall B; Brown C; Mellor AL
Science; 1998 Aug; 281(5380):1191-3. PubMed ID: 9712583
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.
Xiao BG; Liu X; Link H
Steroids; 2004 Sep; 69(10):653-9. PubMed ID: 15465110
[TBL] [Abstract][Full Text] [Related]
6. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.
Friberg M; Jennings R; Alsarraj M; Dessureault S; Cantor A; Extermann M; Mellor AL; Munn DH; Antonia SJ
Int J Cancer; 2002 Sep; 101(2):151-5. PubMed ID: 12209992
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
Kudo Y; Boyd CA; Spyropoulou I; Redman CW; Takikawa O; Katsuki T; Hara T; Ohama K; Sargent IL
J Reprod Immunol; 2004 Apr; 61(2):87-98. PubMed ID: 15063632
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.
Terness P; Bauer TM; Röse L; Dufter C; Watzlik A; Simon H; Opelz G
J Exp Med; 2002 Aug; 196(4):447-57. PubMed ID: 12186837
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection.
Mackler AM; Barber EM; Takikawa O; Pollard JW
J Immunol; 2003 Jan; 170(2):823-30. PubMed ID: 12517946
[TBL] [Abstract][Full Text] [Related]
12. Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase.
Curreli S; Romerio F; Mirandola P; Barion P; Bemis K; Zella D
J Interferon Cytokine Res; 2001 Jun; 21(6):431-7. PubMed ID: 11440641
[TBL] [Abstract][Full Text] [Related]
13. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti.
Suzuki S; Toné S; Takikawa O; Kubo T; Kohno I; Minatogawa Y
Biochem J; 2001 Apr; 355(Pt 2):425-9. PubMed ID: 11284730
[TBL] [Abstract][Full Text] [Related]
14. Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice.
Maeta A; Sano M; Fukuwatari T; Funakoshi H; Nakamura T; Shibata K
Biosci Biotechnol Biochem; 2014; 78(5):878-81. PubMed ID: 25035993
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth.
Kai S; Goto S; Tahara K; Sasaki A; Kawano K; Kitano S
J Exp Ther Oncol; 2003; 3(6):336-45. PubMed ID: 14678522
[TBL] [Abstract][Full Text] [Related]
16. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
[TBL] [Abstract][Full Text] [Related]
17. Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection.
Kudo Y; Boyd CA
Biochim Biophys Acta; 2000 Jan; 1500(1):119-24. PubMed ID: 10564724
[TBL] [Abstract][Full Text] [Related]
18. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of T cell proliferation by macrophage tryptophan catabolism.
Munn DH; Shafizadeh E; Attwood JT; Bondarev I; Pashine A; Mellor AL
J Exp Med; 1999 May; 189(9):1363-72. PubMed ID: 10224276
[TBL] [Abstract][Full Text] [Related]
20. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.
Swanson KA; Zheng Y; Heidler KM; Mizobuchi T; Wilkes DS
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):311-8. PubMed ID: 12959949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
